Sunrise Group secures FDA clearance for home sleep test
Sunrise Group has secured the US Food and Drug Administration (FDA) clearance for Sunrise Air, its latest rechargeable at-home sleep…
19 May 2026
Boston Scientific’s coronary IVL catheter hits primary endpoints in trial
Boston Scientific has shared positive pivotal trial results for its SEISMIQ 4CE Coronary intravascular lithotripsy (IVL) catheter in treating calcified coronary artery disease (CAD). The 420-patient FRACTURE trial (NCT06181240) met its…
19 May 2026
Philips introduces SmartIQ AI software for coronary imaging advancement
Philips has introduced SmartIQ, a new artificial intelligence (AI)-based software algorithm for improving image quality and optimising radiation dosing during coronary imaging procedures. Designed for Philips Azurion image-guided therapy platform,…
19 May 2026
EmStop begins CAPTURE-2 trial of embolic protection system
EmStop has commenced the CAPTURE-2 investigational device exemption (IDE) clinical trial, assessing its embolic protection system during transcatheter aortic valve replacement (TAVR) procedures. The first participants in the CAPTURE-2 study…
19 May 2026
Boston Scientific invests $1.5bn for equity stake in MiRus
Boston Scientific has announced a $1.5bn investment to acquire approximately a 34% equity stake in MiRus, a company developing the SIEGEL Balloon Expandable transcatheter aortic valve replacement (TAVR) system. According…
18 May 2026
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition
Artivion has acquired Endospan in a $135m upfront deal, exercising a license option to buy the Israeli company upon US Food and Drug Administration (FDA) approval for its NEXUS aortic…
18 May 2026
Embecta acquires Owen Mumford for $172.6m
Embecta has completed its acquisition of UK-based medical device manufacturer Owen Mumford Holdings in a deal valued at up to £150m ($172.6m). Initially announced in March 2026, the deal involves…